Merus N.V.
USD90.00
+0.00 (+0.00%)
CEO
Jan van de Winkel
IPO Date
2016-05-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
NL
Open
$90.00
Prev. Close
$90.00
Day Low
$90.00
Day High
$90.00
52W Low
$33.19
52W High
$97.14
Market Cap
$6.83B
Volume
2.72M
| -10.1 |
| 31 Dec 2022 | FY | 74.4% | -315.5% | -49.6% | -32.5% | 0.05 | 3.88 | -5.7 |
| 31 Dec 2021 | FY | -99.9% | -136.1% | -18.6% | -12.9% | 0.01 | 5.90 | -20.9 |
| 31 Dec 2020 | FY | -133.9% | -285.6% | -68.5% | -30.3% | 0.04 | 4.66 | -7.3 |
| 31 Dec 2019 | FY | -78.8% | -177.1% | -37.4% | -18.7% | 0.04 | 6.72 | -7.0 |
| 31 Dec 2018 | FY | -42.7% | -73.8% | -23.5% | -9.9% | 0.03 | 6.75 | -11.0 |
| 31 Dec 2017 | FY | -55.7% | -295.6% | -112.7% | -27.4% | 0.00 | 10.05 | -4.0 |
| 31 Dec 2016 | FY | -634.0% | -1889.9% | -132.5% | -62.4% | 0.01 | 9.17 | -5.6 |
| 31 Dec 2015 | FY | -749.4% | -1220.8% | -82.4% | -59.9% | 0.03 | 5.46 | -6.1 |
| -7.0 |
| 31 Mar 2025 | Q1 | -202.5% | -364.2% | -15.0% | -12.2% | 0.02 | 5.86 | -8.1 |
| 31 Dec 2024 | Q4 | 7.8% | -338.3% | -4.6% | -3.8% | 0.02 | 6.54 | -24.2 |
| 30 Sept 2024 | Q3 | 39.1% | -848.7% | -12.8% | -10.6% | 0.02 | 8.32 | -9.5 |
| 30 Jun 2024 | Q2 | -569.9% | -682.5% | -6.3% | -5.2% | 0.01 | 9.97 | -18.0 |
| 31 Mar 2024 | Q1 | -389.1% | -436.8% | -9.1% | -6.4% | 0.03 | 5.23 | -20.5 |
| 31 Dec 2023 | Q4 | 69.4% | -672.9% | -15.3% | -11.9% | 0.03 | 5.34 | -7.3 |
| 30 Sept 2023 | Q3 | 73.2% | -208.6% | -5.5% | -4.4% | 0.03 | 6.29 | -14.6 |
| 30 Jun 2023 | Q2 | -170.1% | -305.8% | -11.4% | -8.1% | 0.05 | 4.30 | -10.8 |